Determining the cause of death in randomized screening trial(s) for prostate cancer
Authors:
Open Access
- 1 December 2003
- journal article
- case report
- Published by Wiley in BJU International
- Vol. 92 (s2) , 71-78
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Mammographic screening: evidence from randomised controlled trialsAnnals of Oncology, 2003
- Prostate cancer mortality reduction by screening: Power and time frame with complete enrollment in the European randomised screening for prostate cancer (ERSPC) trialInternational Journal of Cancer, 2001
- Large‐scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trialInternational Journal of Cancer, 2001
- Sacred Secrets — The Privacy of Medical RecordsNew England Journal of Medicine, 2001
- Causes of Death in Elderly Prostate Cancer Patients and in a Comparison Nonprostate Cancer CohortJNCI: Journal of the National Cancer Institute, 2000
- Advanced prostate cancer: Course, care, and cost implicationsThe Prostate, 1999
- Breast Cancer as Cause of Death a study over the validity of the officially registered cause of death in 2 631 breast cancer patients dying in Malmö, Sweden 1964–1992Acta Oncologica, 1996
- Determination of Cause of Death Among Breast Cancer Cases in the Swedish Randomized Mammography Screening Trials: A comparison between official statistics and validation by an endpoint committeeActa Oncologica, 1995
- Prostate Cancer Screening: What We Know and What We Need To KnowAnnals of Internal Medicine, 1993
- Advanced breast cancer and its prevention by screeningBritish Journal of Cancer, 1992